These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36780502)

  • 1. Global inequity creates local insufficiency: A qualitative study of COVID-19 vaccine implementation challenges in low-and-middle-income countries.
    Haldane V; Ariyarajah A; Berry I; Loutet M; Salamanca-Buentello F; Upshur REG
    PLoS One; 2023; 18(2):e0281358. PubMed ID: 36780502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions.
    Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I
    Front Public Health; 2021; 9():709127. PubMed ID: 34422750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccination in low and middle-income countries: Creating a sustainable roadmap for promoting public health intervention.
    Oladapo RK; Obidiro OP; Oyetola AB; Olajide A; Oladapo MO; Lawrence US; Hasan MM; Islam Z; Mustapha AA; Osuagwu-Nwogu E; Ghazanfar S; Olaleye MA; Monisola I; Ibraheem B; Afolayan AA; Barakat A; Adewole MO
    Int J Health Plann Manage; 2024 Sep; 39(5):1612-1625. PubMed ID: 39090524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying priority challenges and solutions for COVID-19 vaccine delivery in low- and middle-income countries: A modified Delphi study.
    Ariyarajah A; Berry I; Haldane V; Loutet M; Salamanca-Buentello F; Upshur REG
    PLOS Glob Public Health; 2022; 2(9):e0000844. PubMed ID: 36962787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities to accelerate immunization progress in middle-income countries.
    Zhu J; Cole CB; Fihman J; Adjagba A; Dasic M; Cernuschi T
    Vaccine; 2024 Apr; 42 Suppl 1():S98-S106. PubMed ID: 37460357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research priorities to reduce the impact of COVID-19 in low- and middle-income countries.
    Polašek O; Wazny K; Adeloye D; Song P; Chan KY; Bojude DA; Ali S; Bastien S; Becerra-Posada F; Borrescio-Higa F; Cheema S; Cipta DA; Cvjetković S; Castro LD; Ebenso B; Femi-Ajao O; Ganesan B; Glasnović A; He L; Heraud JM; Igwesi-Chidobe C; Iversen PO; Jadoon B; Karim AJ; Khan J; Biswas RK; Lanza G; Lee SW; Li Y; Liang LL; Lowe M; Islam MM; Marušić A; Mshelia S; Manyara AM; Htay MN; Parisi M; Peprah P; Sacks E; Akinyemi KO; Shahraki-Sanavi F; Sharov K; Rotarou ES; Stankov S; Supriyatiningsih W; Chan BT; Tremblay M; Tsimpida D; Vento S; Glasnović JV; Wang L; Wang X; Ng ZX; Zhang J; Zhang Y; Campbell H; Chopra M; Cousens S; Krstić G; Macdonald C; Mansoori P; Patel S; Sheikh A; Tomlinson M; Tsai AC; Yoshida S; Rudan I
    J Glob Health; 2022; 12():09003. PubMed ID: 35475006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution.
    Agampodi S; Mogeni OD; Chandler R; Pansuriya M; Kim JH; Excler JL
    Expert Rev Vaccines; 2024; 23(1):761-772. PubMed ID: 39167221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs).
    Kahn AL; Steffen CA; Henaff L; MacDonald NE; Morgan C; Faden R; Olayinka F; Desai S
    Vaccine; 2023 Jan; 41(3):676-683. PubMed ID: 36494252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.
    Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H
    Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 related disruption and resilience in immunisation activities in LMICs: a rapid review.
    Hartner AM; Li X; Gaythorpe K
    BMJ Open; 2024 Aug; 14(8):e076607. PubMed ID: 39107008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the prioritization of vaccines by policymakers in low- and middle-income countries: a scoping review.
    Guillaume D; Meyer D; Waheed DE; Schlieff M; Muralidharan K; Chou VB; Limaye R
    Health Policy Plan; 2023 Mar; 38(3):363-376. PubMed ID: 36315461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccine attitudes among a majority black sample in the Southern US: public health implications from a qualitative study.
    Huang W; Dove-Medows E; Shealey J; Sanchez K; Benson L; Seymore DD; Sullivan PS; Bradley HM; Siegler AJ
    BMC Public Health; 2023 Jan; 23(1):88. PubMed ID: 36631819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
    Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
    Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Learn from the lessons and don't forget them': identifying transferable lessons for COVID-19 from meningitis A, yellow fever and Ebola virus disease vaccination campaigns.
    Collins J; Westerveld R; Nelson KA; Rohan H; Bower H; Lazenby S; Ikilezi G; Bartlein R; Bausch DG; Kennedy DS
    BMJ Glob Health; 2021 Sep; 6(9):. PubMed ID: 34535490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes and costs of global COVID-19 vaccine inequity.
    Ferranna M
    Semin Immunopathol; 2024 Jan; 45(4-6):469-480. PubMed ID: 37870569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of COVID-19 on the neglected tropical diseases: a scoping review.
    Butala CB; Cave RNR; Fyfe J; Coleman PG; Yang GJ; Welburn SC
    Infect Dis Poverty; 2024 Jul; 13(1):55. PubMed ID: 39075616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The whole-of-society approach of mass COVID-19 vaccination in China: a qualitative study.
    Wang Q; Qu Z; Tu S; Chen X; Hou Z
    Health Res Policy Syst; 2022 Dec; 20(1):142. PubMed ID: 36585666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risky business: COVAX and the financialization of global vaccine equity.
    Stein F
    Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COVID-19 Vaccination and Vaccine Inequity Worldwide: An Empirical Study Based on Global Data.
    Ning C; Wang H; Wu J; Chen Q; Pei H; Gao H
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564661
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.